| Returns | 1W : -0.4% , 1M : 4.3%,1Y : NA |
| Peers & Returns | 1W | 1M | 1Y |
| SUVEN PHARMACEUTICALS LTD | -0.4% | 4.3% | NA |
| SUN PHARMACEUTICAL INDUSTRIES LTD | -0.1% | 5.5% | 56.9% |
| DR REDDYS LABORATORIES LTD | -0.8% | -9.3% | 44.9% |
| DIVIS LABORATORIES LTD | -3.6% | -1.7% | 62.4% |
| CIPLA LTD | -0.8% | -6.5% | 90.2% |
| BIOCON LTD | -1.9% | 2.6% | 30.9% |
| AUROBINDO PHARMA LTD | -0.4% | -9.5% | 71.2% |
| LUPIN LTD | 2.3% | -3% | 53% |
| TORRENT PHARMACEUTICALS LTD | -0.5% | -8.8% | 11.5% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
22.6
P/E Calculated based on EPS of 21.22
[ Mar2020 - Standalone Results ] 7.8
P/B Calculated based on Book Value of 61.5
[ Mar2020 - Standalone Results ] 15.28
P/S Calculated based on Revenues of 799.094 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
422% NA (-ve EV) 396% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
